INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 864
26/07/2024
Projectes
03/09/2024
EHA - EUROPEAN HEMATOLOGY ASSOCIATION
1-year grant intended to support basic and translational early career researchers in hematology and allow them to test a high-risk but potentially high impact idea that is lacking solid preliminary data.
 
12/09/2024
ISCIII - INSTITUTO DE SALUD CARLOS III
Promoure la investigació orientada a resultats en salut mitjançant la coordinació del teixit investigador a l'àmbit del SNS al voltant d'un objectiu de recerca concret i definit, d'utilitat específica per al conjunt de la ciutadania.
 
Recursos Humans
10/09/2024
FEHH - FUNDACION ESPAÑOLA DE HEMATOLOGIA Y HEMOTERAPIA
La FEHH convoca un programa de 10 beques per a gaudir en 2025: 7 de la FEHH, 2 en col·laboració amb Janssen (FEHH/Janssen), 1 en col·laboració amb AstraZeneca (FEHH/AstraZeneca).
Les Ajudes van dirigides a socis de la Societat Espanyola d'Hematologia i Hemoteràpia (SEHH) que desitgin realitzar un projecte de recerca en un centre espanyol, en l'àmbit de les àrees que conformen l'especialitat d'Hematologia i Hemoteràpia. Les 2 Ajudes de col·laboració FEHH/*Janssen quedaran circumscrites a l'àrea d'hemopaties malignes, amb prioritat per al mieloma múltiple i les síndromes limfoproliferatives cròniques. L'ajuda en col·laboració amb AstraZeneca també quedarà circumscrita a l'àrea de la leucèmia limfocítica crònica LLC.
 
24/11/2024
ECTRIMS - EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS
ECTRIMS offers a postdoctoral research fellowship exchange programme for young neuroscientists to facilitate their conduct of and training in basic, clinical or applied research related to multiple sclerosis (MS).
 
 
 
Informació últil
 
 No hi ha novetats
 
 
Banner-convocatories-tancament-02
Projectes
22/08/2024
COMISSIÓ EUROPEA
Advanced Grants are designed to support excellent Principal Investigators at the career stage at which they are already established research leaders with a recognised track record of research achievements. Applicant Principal Investigators must demonstrate the ground-breaking and high-gain/high-risk nature of their scientific proposal.
 
23/08/2024
GEIS - GEIS - GRUPO ESPAÑOL DE INVESTIGACION EN SARCOMAS y GEIGO
Obtenir propostes originals de projectes de recerca que reverteixin en l'avanç de la terapèutica clínica i en la millora del coneixement dels sarcomes per a un projecte original de recerca translacional en el camp dels sarcomes, que serà desenvolupat en un centre nacional.
 
08/08/2024
FARA - FRIEDREICH'S ATAXIA RESEARCH ALLIANCE
FARA supports research through funding competitive grants across the spectrum from basic research through drug development and clinical research programs in Friedreich's Ataxia (FA).
 
Borses de viatge
23/08/2024
JSPS - JAPAN SOCIETY FOR PROMOTION OF SCIENCE (JSPS)
To provide opportunities for excellent postdoctoral researchers from other countries to conduct, under the guidance of their hosts, cooperative research with leading research groups in universities and other Japanese institutions.
 
24/08/2024
JSPS - JAPAN SOCIETY FOR PROMOTION OF SCIENCE (JSPS)
To invite overseas researchers with excellent records of research achievements to collaborate with Japanese colleagues in carrying out research through long-term visits.
 
05/08/2024
UICC-GLOBAL CANCER CONTROL
Short-term international fellowship opportunities to cancer professionals.
 
25/08/2024
FUNDACIÓ ACADÈMIA DE CIÈNCIES MÈDIQUES I DE LA SALUT DE CATALUNYA I BALEARS
Proporcionar als residents en l’últim any de l’especialitat d’Oncologia Radioteràpica o als especialistes en Oncologia Radioteràpica en un Hospital acreditat de Catalunya, l’oportunitat d’ampliar o d’actualitzar la seva formació, tant clínica com de recerca, a un o més centres de l’estranger.
 
23/08/2024
EHA - EUROPEAN HEMATOLOGY ASSOCIATION
Through the CRTH, EHA provides junior researchers with a 9-month long unique training and mentoring experience focused on clinical research in Europe, with a global scope. After participating in CRTH, you have improved your skills and knowledge to benefit your work and career in clinical science.
 
Premis
09/08/2024
MINISTERIO DE CIENCIA, INNOVACIÓN Y UNIVERSIDADES
La concessió dels Premis Nacionals de Recerca es pretén reconèixer el mèrit de persones investigadores espanyoles.
La concessió dels Premis Nacionals de Recerca per a Joves es pretén reconèixer el mèrit de persones investigadores espanyoles amb edat màxima de 40 anys que estiguin fent un treball excel·lent i hagin aconseguit assoliments rellevants en les seves respectives àrees de recerca.
 
25/08/2024
Grete Lundbeck European Brain Research Foundation
‘The Brain Prize’- is awarded to one or more scientists who have distinguished themselves by an outstanding contribution to European neuroscience and who are still active in research.
 
24/08/2024
PSICOFUNDACION - FUNDACIÓN ESPAÑOLA PARA LA PROMOCIÓN Y EL DESARROLLO CIENTÍFICO Y PROFESIONAL DE LA PSICOLOGÍA
Amb l'objectiu de fomentar la iniciativa, la creativitat i la innovació dels joves psicòlegs espanyols i dels països llatinoamericans.
 
24/08/2024
JOHN WILEY & SONS LIMITED
The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality, and impact on our understanding of biological systems and processes.
 
24/08/2024
FUNDACIÓN BIAL
The Prémio BIAL de Medicina Clínica seeks to recognize an intellectual, original work on any freely chosen medical topic on clinical practice.
 
Recursos Humans
25/08/2024
CRI - CANCER RESEARCH INSTITUTE
The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.
 
 
 
 
Articles
 
Lafuente J, Patino JD, Capo L. Management of Low and High Grades Spondylolisthesis. Adv Tech Stand Neurosurg 2024; 49: 51-72.
 
Mar J*, Larrañaga I, Ibarrondo O, González-Pinto A, Hayas CL, Fullaondo A, Izco-Basurko I, Alonso J, Mateo-Abad M, de Manuel E, UPRIGHT Consortium. Socioeconomic and gender inequalities in mental disorders among adolescents and young adults. Span J Psychiatry Ment Health . 2024; 17(2): 95-102.
 
Gualdi F, Oliva B, Piñero J*. Predicting gene disease associations with knowledge graph embeddings for diseases with curtailed information. NAR Genomics and Bioinformatics 2024; 6(2): lqae049 (Acceptat).
 
Cherrez-Ojeda I*, Bousquet J, Giménez-Arnau AM, Godse K, Krasowska D, Bartosinska J, Szczepanik-Kulak P, Wawrzycki B, Kolkhir P, Allenova A, Allenov A, Tkachenko S, Mitrevska NT, Mijakoski D, Stoleski S, Kolacinska-Flont M, Kuprys-Lipinska I, Molinska J, Kasperska-Zajac A, Zajac M, Zamlynski M, Mihaltan F, Ulmeanu R, Zalewska-Janowska A, Tomaszewska K, Al-Ahmad M, Al-Nesf MA, Ibrahim T, Aqel S, Pesqué D, Rodriguez-Gonzalez M, Wakida-Kuzunoki GH, Ramon GD, Ramon GN, Neisinger S, Bonnekoh H, Rukhadze M, Khoshkhui M, Fomina D, Larenas-Linnemann D, Kosnik M, Kara RO, Caballero-López CG, Liu Q, Ivancevich JC, Ensina LF, Rosario N, Kvedariene V, Ben-Shoshan M, Jardim-Criado RF, Bauer A, Cherrez A, Cherrez S, Chong-Neto H, Rojo-Gutierrez MI, Rudenko M, Larco-Sousa JI, Lesiak A, Matos E, Tinoco I, Crespo-Shijin C, Hinostroza-Logroño R, Sagñay J, Faytong-Haro M, Robles-Velasco K, Zuberbier T, Maurer M*. Usage prevalence of angioedema patient-reported outcome measures: Results from the UCARE and ACARE PROMUSE study. J Allergy Clin Immunol Pract 2024: (en Premsa).
 
Abril-Pérez C, Mansilla-Polo M*, Escutia-Muñoz B, Sanmartín O, Garcés JR, Rodríguez-Prieto MA, Ruiz-Salas V, de Eusebio Murillo E, Miñano R, Gonzalez-Sixto B, Artola Igarza JL, Alfaro Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez J, Allende Markixana I, Alonso-Pacheco ML, Garcia-Bracamonte B, De la Cueva-Dobao P, Navarro R, Ciudad C, Carnero-González L, Vázquez-Veiga H, Cano-Martinez N, Serra-Guillén C, Vilarrasa E, Sánchez-Sambucety P, López-Estebaranz JL, Florez-Menéndez A, Martorell-Calatayud A, Gil P, Morales-Gordillo V, Toll A, Ocerin-Guerra I, Mayor Arenal M, Suarez Fernández R, Sainz-Gaspar L, Descalzo MA, García-Doval I, Botella-Estrada R, REGESMOHS (Registro Español de Cirugía de Mohs). Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery). J Eur Acad Dermatol Venereol 2024: (en Premsa).
 
Dadvand P*, Gascon M, Bustamante M, Rivas I, Foraster M, Basagaña X, Cosín M, Eixarch E, Ferrer M, Gratacós E, GÓMEZ L, ARENAS J, Julvez J, Morillas À, Nieuwenhuijsen M, Persavento C, Pujol J, Querol X, Sánchez-García O, Vrijheid M, Llurba E, Gómez-Roig MD, Sunyer J, BiSC Group. Cohort Profile: Barcelona Life Study Cohort (BiSC). Int J Epidemiol 2024; 53(3): dyae063.
 
Lopez Montesinos I, Carot-Coll A, Montero MM, Sorli L, Siverio-Pares A, Esteban-Cucó S, Duran X, Gómez-Zorrilla S*, Horcajada JP. A case-control study of the clinical and economic impact of infections caused by Carbapenemase-producing Enterobacterales (CPE). Infection 2024: (en Premsa).
 
Szántó M, Yelamos J*, Bai P*. Specific and shared biological functions of PARP2 - is PARP2 really a lil' brother of PARP1?. Expert Rev Mol Med . 2024; 26: e13.
 
Nerin F, Caprai C, Morales A, López M, Aranda D, Giorgino T*, Selent J*. AlloViz: A tool for the calculation and visualisation of protein allosteric communication networks. Comput Struct Biotechnol J . 2024; 23: 1938-1944 (Acceptat).
 
Climent E*, González-Guerrero A, Marco-Benedí V, García-Andreu MD, Mediavilla-García JD, Suárez-Tembra M, Benaiges D, Pintó X, Pedro-Botet J. Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors. Int J Mol Sci 2024; 25(9): 4831.
 
Rua-Figueroa I*, Altabás-González I, Mouriño C, Roberts K, Hernández-Martín A, Casafont-Sole I, Font-Urgelles J, Román-Ivorra J, Navarro MR, Galindo-Izquierdo M, Salman-Monte TC, Narváez J, Vidal-Montal P, García-Villanueva MJ, Garrote-Corral S, Blázquez-Cañamero MÁ, Marras C, Piqueras-García M, Martínez-Barrio J, Sánchez-Lucas M, Cortés-Hernández J, Penzo E, Calvo J, de Dios JR, Rodríguez BÁ, Vasques-Rocha M, Tomero E, Menor-Almagro R, Gandía M, Gómez-Puerta JA, Frade-Sosa B, Ramos-Giráldez C, Trapero-Pérez C, Diez E, Moriano C, Muñoz-Jiménez A, Pego-Reigosa J. Can the Dose of Belimumab be Reduced in Patients with Systemic Lupus Erythematosus?. Rheumatology 2024: (en Premsa).
 
Serradilla-Martín M*, Villodre C, Falgueras-Verdaguer L, Zambudio-Carroll N, Castell-Gómez J, Blas-Laina JL, Borrego-Estella V, Domingo-del Pozo C, García-Plaza G, González-Rodríguez FJ, Montalvá-Orón EM, Moya-Herraiz AA, Paterna-López S, Suárez-Muñoz MÁ, Alkorta-Zuloaga M, Blanco-Fernández G, Dabán-Collado E, Gómez-Bravo MÁ, Miota-de-llamas JI, Rotellar F, Sánchez-Pérez B, Sánchez-Cabús S, Pacheco-Sánchez D, Rodríguez-Sanjuan JC, Varona-Bosque MA, Carrión-Álvarez L, de la Serna-Esteban S, Dopazo C, Martin-Perez E, Martínez-Cecilia D, Castro-Santiago MJ, Dorcaratto D, Gutiérrez-Díaz ML, Asencio-Pascual JM, Burdío F, Carracedo-iglesias R, Escartín-Arias A, Ielpo B, Rodriguez-Laiz G, Valdivieso-López A, De-Vicente-López E, Alonso-Orduña V, Ramia JM. Feasibility and Short-Term Outcomes in Liver-First Approach: A Spanish Snapshot Study (the RENACI Project). Cancers 2024; 16(9): 1676.
 
Halimi JM*, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, Camafort M, Chapman N, Cottone S, De Backer, Deinum J, Delmotte P, Dorobantu M, Doumas M, Dusing R, Duly-bouhanick B, Fauvel JP, Fesler P, Gaciong Z, Gkaliagkousi E, Gordin D, Grassi G, Grassos C, Guerrot D, Huart J, Izzo R, Águila FJ, Járai Z, Kahan T, Kantola I, Kociánová E, Limbourg FP, Lopez-Sublet M, Mallamaci F, Manolis A, Marketou M, Mayer G, Mazza A, Macintyre IM, Mourad JJ, Muiesan ML, Nasr E, Nilsson P, Oliveras A, Ormezzano O, Paixão-dias V, Papadakis I, Papadopoulos D, Perl S, Polónia J, Pontremoli R, Pucci G, Robles NR, Rubin S, Ruilope LM, Rump LC, Saeed S, Sanidas E, Sarzani R, Schmieder R, Silhol F, Sokolovic S, Solbu M, Soucek M, Stergiou G, Sudano I, Tabbalat R, Tengiz I, Triantafyllidi H, Tsioufis K, Václavík J, van der Giet M, Van der Niepen P, Veglio F, Venzin RM, Viigimaa M, Weber T, Widimsky J, Wuerzner G, Zelveian P, Zebekakis P, Lueders S, Persu A, Kreutz R, Vogt L, European Society of Hypertension Working Group on Hypertension, the Kidney. Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire. J Hypertens 2024: (en Premsa).
 
Barbero-Allende JM*, Fernández-Antón E, Gómez J, Sorli L, Rodriguez-Pardo D, Murillo-Rubio O, Fernández-Sampedro M, Escudero-Sánchez R, Garcia-Gutiérrez M, Portillo ME, Sancho I, Rico-Nieto A, Guio-Carrion L, Soriano-Viladomiu A, Morata-Ruiz L, De Abajo-Iglesias F. Impact of antibiotic prophylaxis in second-stage surgery in joint prosthesis infection treated with two-stage exchange. A multicenter case-control study. Eur J Clin Microbiol Infect Dis 2024: (en Premsa).
 
Cámara A*, Compta Y, Baixauli M, Maragall L, Pérez-Soriano A, Montagut N, Ahuir M, Ludeña E, Peri L, Fernández N, Villote S, Lopez-de los Reyes JC, Navarro-Otano J, Zaro I, Muñoz E, Buongiorno M, Caballol N, Pont-Sunyer C, Puente VM, Giraldo D, Valldeoriola F, Lombraña M, Martí MJ. Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study. Parkinsonism Relat Disord 2024; 124: 106993.
 
Marqués F*, Pares-Alfonso I, Donaire-Hoyas D, Ruiz-Morales G, Tey M, Lizano-Díez X, León A. Total Hip Replacement with a Fully Hydroxyapatite-Coated Shortened Stem: Five- to Thirteen-Year Follow-Up Results. J Clin Med 2024; 13(9): 2657.
 
Voskanyan V, Marzorati C*, Sala D, Grasso R, Pietrobon R, van der Heijden I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Velikova G, Brunelli C, Apolone G, Pravettoni G. Psychosocial factors associated with quality of life in cancer survivors: umbrella review. J Cancer Res Clin 2024; 150(5): 249.
 
D'Aniello S, Rustici A, Gramegna LL*, Godi C, Piccolo L, Gentile M, Zini A, Carrozzi A, Lodi R, Tonon C, Dall'olio M, Simonetti L, Chieffo R, Anzalone N, Cirillo L. The Contribution of Vessel Wall Magnetic Resonance Imaging to the Diagnosis of Primary and Secondary Central Nervous System Vasculitis. Diagnostics 2024; 14(9): 927.
 
Sahuquillo-Torralba A, Mansilla-Polo M*, Pujol-Marco C, Llamas-Velasco M, Rull EV, Ruíz-Villaverde R, Ferran M, Pitarch G, Lopez A, Beltran E, Urruticoechea-Arana A, Riera-Monroig J, Alsina M, Vidal D, Belinchón-Romero I, Notario J, Carrascosa JM, Gonzalez-Delgado V, Mollet J, Ribera M, Gallardo F. Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group. Int J Dermatol 2024: (en Premsa).
 
González-Aranceta N, Alomar A, Rubio R, Maya S, Payà Panadés A, Piella G, Sukno F*. Accuracy and repeatability of fetal facial measurements in 3D ultrasound: A longitudinal study. Early Hum Dev 2024; 193: 106021.
 
Williams P*, Cotta MO, Tabah A, Sandaradura I, Kanji S, Scheetz MH, Imani S, Elhadi M, Luque S, Schellack N, Sanches C, Timsit JF, Xie J, Farkas A, Wilks K, Roberts JA, European Society of Intensive Care Medicine (ESICM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients [ESGCIP]. Antimicrobial therapeutic drug monitoring in critically ill adult patients - An international perspective on access, utilisation, and barriers. Int J Antimicrob Ag 2024; 64: (en Premsa).
 
 
Tel: 93 316 04 00
Doctor Aiguader, 88
08003 Barcelona
Seguiu-nos a:
Twitter
Youtube
En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).